日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Heavy Drinking, Alcohol Use Disorder, and Obesity

酗酒、酒精使用障碍和肥胖

Shuey, Bryant; Anderson, Timothy S; Wharam, James Franklin; Liebschutz, Jane M; Luo, Jing; Suda, Katie J; Bernstein, Eden Y

Barriers to Buprenorphine Initiation in Patients Using Fentanyl

使用芬太尼的患者开始使用丁丙诺啡的障碍

Kawasaki, Sarah S; Liebschutz, Jane M; Murray-Krezan, Cristina; Switzer, Galen E; Nash, Samantha; Jeong, Kwonho; Winstanley, Erin L

Perspectives on Harm Reduction Kit Implementation in Heterogeneous Outpatient Clinics

关于在异质性门诊诊所实施减害工具包的观点

Jawa, Raagini; Shang, Margaret; Markus, Austen; Hamm, Megan; Luiggi-Hernández, José G; de Abril Cameron, Flor; McMurtrie, Gary; Studnicki, Olivia; Hawk, Mary; Check, Devon K; Merlin, Jessica; Liebschutz, Jane M

Sex-Based Differences in Binge and Heavy Drinking Among US Adults

美国成年人酗酒和重度饮酒行为的性别差异

Shuey, Bryant; Wen, Hefei; Suda, Katie J; Burnett, Alyssa; Wharam, James Franklin; Anderson, Timothy S; Liebschutz, Jane M

Postoperative Opioid Prescribing Among Adults with Disabilities After a Medicare Opioid Limit Policy

医疗保险阿片类药物限制政策实施后,残疾成年人术后阿片类药物处方情况

Shuey, Bryant; Wharam, James Franklin; Burnett, Alyssa; Thomas, Ann M; Argetsinger, Stephanie; Zhang, Fang; Johnston, Kenton J; Suda, Katie J; Liebschutz, Jane M; Wen, Hefei

Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone on treatment interruption: Comparing findings from a reanalysis of the X:BOT RCT and harmonized target trial emulation using population-based observational data

缓释纳曲酮与丁丙诺啡-纳洛酮在治疗中断方面的比较疗效:基于人群观察数据的X:BOT RCT再分析与统一目标试验模拟研究结果的比较

Lodi, Sara; Yan, Shapei; Bovell-Ammon, Benjamin; Christine, Paul J; Hsu, Heather E; Bernson, Dana; Novo, Patricia; Lee, Joshua D; Rotrosen, John; Liebschutz, Jane M; Walley, Alexander Y; Larochelle, Marc R

Physical and Mental Health Services in Opioid Treatment Programs

阿片类药物治疗项目中的身心健康服务

Shuey, Bryant; Joudrey, Paul J; Anderson, Timothy S; Park, Tae Woo; Liebschutz, Jane M

"To not feel fake, it can't be fake": co-creation of a harm reduction, peer-delivered, health-system intervention for people who use drugs

“为了不让人觉得虚假,它就不能是虚假的”:为吸毒者共同创建一项由同伴提供的、以减少伤害为目标的医疗系统干预措施

Wilson, J Deanna; Klipp, Stephanie P; Leon, Kelsey; Liebschutz, Jane M; Merlin, Jessica; Murray-Krezan, Cristina; Nolette, Sommer; Phillips, Kristina T; Stein, Michael; Weinstock, Nate; Hamm, Megan

Identifying Barriers and Facilitators to Pain Management With Buprenorphine for Patients With Kidney Failure: A Thematic Analysis of Interviews With Key Partners

识别使用丁丙诺啡治疗肾衰竭患者的疼痛管理障碍和促进因素:对关键合作伙伴访谈的主题分析

Kallem, Cramer J; Hamm, Megan E; Cameron, Flor; Cavanaugh, Kerri L; Eneanya, Nwamaka D; Bulls, Hailey W; Wilkie, Caroline; Edwards, Karlyn A; Olejniczak, Donna M; Liebschutz, Jane M; Jhamb, Manisha

Why is substance use missing from my patient's problem list? CTN research to advance screening, prevention, and treatment of substance use in primary care

为什么我的病人问题列表中没有物质滥用?CTN 研究旨在推进初级保健中物质滥用的筛查、预防和治疗。

McNeely, Jennifer; Bradley, Katharine A; Liebschutz, Jane M; Subramaniam, Geetha A